The effect of L-carnitine on myocardial protection in cold cardioplegia followed by reperfusion.
We studied the effect of exogenous L-carnitine on myocardial viability and carnitine uptake following ischemia-reperfusion in isolated rat hearts. Hearts were subjected to hypothermic cardioplegia at 26 degrees C for 80 minutes with and without carnitine 10 mmol/L added to the perfusate and cardioplegic solution [Groups I (n = 9) and II (n = 14), respectively]. Additionally, to study myocardial carnitine uptake, hearts were subjected to global ischemia at 20 degrees C [Group III (n = 6) and IV (n = 6)] and at 37 degrees C [Group V (n = 6) and VI (n = 6)] with and without carnitine 10 mmol/L added to the perfusate. All hearts received normothermic reperfusion, and Krebs-Henseleit solution was used as the perfusate in all groups. Postischemic aortic flow, expressed as the percentage of pre-ischemic flow, morphometric scores of myocardial mitochondria, and the myocardial concentration of adenosine triphosphate at the end of reperfusion were significantly higher in Group I than in Group II. In hearts treated with L-carnitine both at 20 degrees C and 37 degrees C the myocardial concentrations of carnitine fractions (free, short-acyl, and long-acyl) increased significantly compared to those in hearts without L-carnitine treatment. The myocardial concentration of free carnitine at the end of reperfusion was significantly higher in Group III than at pre-ischemia. These results suggest that exogenous L-carnitine is incorporated into cellular metabolism, even in hypothermic cardioplegia, improving cardiac function and preserving the myocardial adenosine triphosphate concentration.